Literature DB >> 3112092

The effect of sublethal levels of antibiotics on the pathogenicity of Pseudomonas aeruginosa for tracheal tissue.

T A Geers, N R Baker.   

Abstract

Hamster tracheal organ cultures were used to evaluate the ability of two aminoglycoside and two beta-lactam antibiotics to protect the epithelium from damage due to Pseudomonas aeruginosa infection. Hamster tracheal explants were infected with strains of P. aeruginosa for 4 h and washed to remove nonadherent organisms. The explants were incubated for an additional 18 h in fresh minimal essential medium containing inhibitory or subinhibitory concentrations of antibiotics. The explants were examined by scanning electron microscopy and bacterial elastase and exotoxin A production was detected by ELISA and a western blot assay respectively. Concentrations of aminoglycosides below the MIC for the infecting strain protected the epithelium from damage and inhibited the production of exotoxin and elastase. The beta-lactam antibiotics were not protective and epithelial damage was observed at antibiotic levels equal to or higher than the MIC for that strain. The beta-lactam treated cultures continued to release elastase and exotoxin A at antibiotic concentrations equivalent to or higher than the MIC for that strain. Thus subinhibitory levels of aminoglycoside antibiotics could protect the infected epithelium from damage by inhibiting the release of toxic substances from the invading bacteria. In contrast, bacteria exposed to beta-lactam antibiotics may continue to release extracellular toxins which can damage the tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112092     DOI: 10.1093/jac/19.5.569

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.758


  11 in total

1.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

Review 2.  Microbiology of cystic fibrosis lung infections: themes and issues.

Authors:  J R Govan; J W Nelson
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

3.  Hydrophobicity and outer membrane proteins of Shigella dysenteriae type 1 after treatment with subinhibitory concentrations of aminoglycosides.

Authors:  A Hostacká; E Karelová
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.099

4.  Pseudomonas aeruginosa and cystic fibrosis: Antibiotic therapy and the science behind the magic.

Authors:  N E Macdonald
Journal:  Can J Infect Dis       Date:  1997-11

Review 5.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Enzymic and permeability activity of Pseudomonas aeruginosa after treatment with sub-MICs of organic ammonium salts.

Authors:  A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

Review 7.  Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Authors:  Susan M Cheer; John Waugh; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Effects of subinhibitory concentrations of antibiotics on biological properties of Salmonella typhimurium.

Authors:  L Majtánová; A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

9.  Alterations in Pseudomonas aeruginosa exoproducts by sub-MICs of some antibiotics.

Authors:  A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

10.  Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.

Authors:  K Grimwood; M To; H R Rabin; D E Woods
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.